for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Fisher & Paykel Healthcare Corp Ltd

FPH.NZ

Latest Trade

31.64NZD

Change

-0.64(-1.98%)

Volume

413,143

Today's Range

31.64

 - 

32.75

52 Week Range

21.10

 - 

37.89

As of on the New Zealand Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
32.28
Open
32.35
Volume
413,143
3M AVG Volume
17.96
Today's High
32.75
Today's Low
31.64
52 Week High
37.89
52 Week Low
21.10
Shares Out (MIL)
576.12
Market Cap (MIL)
18,234.93
Forward P/E
41.98
Dividend (Yield %)
1.00

Next Event

Full Year 2021 Fisher & Paykel Healthcare Corporation Ltd Earnings Release

Latest Developments

More

Fisher & Paykel Healthcare Corporation Posts HY Net Profit After Tax Of $225.5 Mln, Up 86%

Fisher & Paykel Healthcare Says Commenced Planning For 3rd Manufacturing Facility In Mexico

Fisher & Paykel Healthcare Sees FY21 Operating Revenue Of About NZ$1.61 Bln

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Fisher & Paykel Healthcare Corp Ltd

Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by entities or employees based in the United Kingdom, France, Germany, Sweden, Turkey and Russia, and Asia-Pacific, which includes all activities controlled by entities or employees based in Australia, Japan, India, China, South Korea, Taiwan and Hong Kong, and Other segment includes New Zealand, Latin America, Africa, the Middle East and other countries.

Industry

Medical Equipment & Supplies

Contact Info

15 Maurice Paykel Place, East Tamaki

1061

New Zealand

+64.9.5740100

https://www.fphcare.com/

Executive Leadership

Antony John Carter

Non-Executive Independent Chairman of the Board

Lewis George Gradon

Chief Executive Officer, Managing Director, Director

Lyndal Jane York

Chief Financial Officer

Paul Nigel Shearer

Senior Vice President - Sales and Marketing

Debra Lumsden

Vice President of Human Resources Officer

Key Stats

3.43 mean rating - 7 analysts
Sell
Hold
Buy
Revenue (MM, NZD)

2018

1.0K

2019

1.1K

2020

1.3K

2021(E)

1.8K
EPS (NZD)

2018

0.330

2019

0.362

2020

0.496

2021(E)

0.769
Price To Earnings (TTM)
46.82
Price To Sales (TTM)
11.38
Price To Book (MRQ)
14.90
Price To Cash Flow (TTM)
39.57
Total Debt To Equity (MRQ)
8.98
LT Debt To Equity (MRQ)
3.27
Return on Investment (TTM)
33.31
Return on Equity (TTM)
27.13

Latest News

Latest News

Fisher & Paykel, ResMed settle global patent disputes; shares jump

New Zealand medical device maker Fisher & Paykel Healthcare Corp Ltd and U.S. rival ResMed Inc have agreed to settle patent infringement disputes, ending a three-year tussle that spanned the globe and cost each side millions of dollars in legal fees.

NZ's Fisher & Paykel and ResMed settle global patent disputes

Medical device maker Fisher & Paykel Healthcare and U.S.-based ResMed on Thursday agreed to settle disputes over patent infringement, bringing to an end a tussle spanning the globe.

NZ's Fisher & Paykel Healthcare files complaint in the U.S. against Resmed

Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint against California-based Resmed, alleging it infringed five of its patents related to sleep apnea devices.

NZ's Fisher & Paykel Healthcare files patent infringement complaint against ResMed

Medical device maker Fisher & Paykel Healthcare said on Tuesday it had filed a patent infringement complaint in the United States against ResMed .

UPDATE 1-NZ's Fisher & Paykel cuts FY guidance on ResMed-linked legal costs

New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

NZ's Fisher & Paykel Healthcare cuts FY guidance on higher expected legal costs

New Zealand medical device firm Fisher & Paykel Healthcare Corp cut its fiscal 2019 net profit outlook on Monday on the back of expected legal costs to contest patent allegations made by ResMed Inc.

NZ's Fisher & Paykel Healthcare upgrades guidance on weaker local currency

New Zealand medical device firm Fisher & Paykel Healthcare on Thursday raised its full-year profit guidance by more than two percent as it benefited from a weakening in the New Zealand dollar.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up